Surgery Partners (SGRY) Cost of Revenue (2014 - 2026)

Surgery Partners has disclosed Cost of Revenue across 13 years of filings, most recently posting $220.2 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $220.2 million, up 405.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $378.0 million (up 4.94% YoY), and the FY2025 annual result was $201.4 million, down 75.22% from the prior year.
• Cost of Revenue came in at $220.2 million for Q1 2026 at Surgery Partners, up from $53.4 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $592.9 million in Q4 2022 to a low of -$374.5 million in Q4 2023.
• The 5-year median for Cost of Revenue is $45.6 million (2023), against an average of $73.8 million.
• Across the five-year window, Cost of Revenue soared 1648.97% in 2022 and sank 163.16% in 2023, its largest moves.
• Surgery Partners' Cost of Revenue stood at $592.9 million in 2022, then tumbled by 163.16% to -$374.5 million in 2023, then jumped by 159.55% to $223.0 million in 2024, then plunged by 76.05% to $53.4 million in 2025, then jumped by 312.36% to $220.2 million in 2026.
• The last three Cost of Revenue figures came in at $220.2 million (Q1 2026), $53.4 million (Q4 2025), and $49.0 million (Q3 2025), per Business Quant data.